# Ketamine for Acute Painful Crisis in Sickle Cell Disease Patients

> **NCT03431285** · NA · COMPLETED · sponsor: **Imam Abdulrahman Bin Faisal University** · enrollment: 278 (actual)

## Conditions studied

- Sickle Cell Crisis

## Interventions

- **DRUG:** Morphine Group
- **DRUG:** Ketamine Group
- **OTHER:** standard IV hydration

## Key facts

- **NCT ID:** NCT03431285
- **Lead sponsor:** Imam Abdulrahman Bin Faisal University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-01
- **Primary completion:** 2019-01-10
- **Final completion:** 2019-02-01
- **Target enrollment:** 278 (ACTUAL)
- **Last updated:** 2025-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03431285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03431285, "Ketamine for Acute Painful Crisis in Sickle Cell Disease Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03431285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*